The AI Health Podcast

Drug Discovery's AI Paradigm Shift with Dr. Abraham Heifets (Atomwise)

Episode Summary

Our guest today is Dr. Abraham Heifets, CEO and Co-Founder of Atomwise, whose research on AI-enhanced drug discovery was featured in the July 2019 Moonshot issue of Newsweek. He discusses Atomwise's pioneering work on the use of deep convolutional neural networks for faster drug discovery, allowing researchers to screen billions of molecules in a matter of days.

Episode Notes

Our guest today is Dr. Abraham Heifets, CEO and Co-Founder of Atomwise, whose research on AI-enhanced drug discovery was featured in the July 2019 Moonshot issue of Newsweek. He discusses Atomwise's pioneering work on the use of deep convolutional neural networks for faster drug discovery, allowing researchers to screen billions of molecules in a matter of days. Pranav and Adriel first give an overview of drug discovery and provide context for the interview, which starts at 7:10. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.